Comparison between Arete 22 IPO and Biopol Chemicals IPO.
Arete 22 IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Biopol Chemicals IPO is a SME Bookbuilding proposed to list at NSE SME.
| Arete 22 IPO | Biopol Chemicals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | NSE SME |
| Lead Managers | Horizon Management Pvt.Ltd. | Smart Horizon Capital Advisors Pvt.Ltd. |
| Registrar | MAS Services Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Shreni Shares Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Arete 22 IPO is up to ₹0.00 Cr whereas the issue size of the Biopol Chemicals IPO is up to ₹29.63 Cr. The final issue price of Arete 22 IPO is and of Biopol Chemicals IPO is ₹108.00 per share.
| Arete 22 IPO | Biopol Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹102.00 per share | |
| Issue Price (Upper) | ₹108.00 per share | |
| Issue Price (Final) | ₹108.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | |
| Fresh Issue Size | 56,50,000 shares | 27,43,200 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹29.63 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 56,50,000 shares | 27,43,200 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹29.63 Cr |
Arete 22 IPO opens on , while Biopol Chemicals IPO opens on Feb 06, 2026. The closing date of Arete 22 IPO and Biopol Chemicals IPO is , and Feb 10, 2026, respectively.
| Arete 22 IPO | Biopol Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 06, 2026 | |
| Issue Close | Feb 10, 2026 | |
| Basis Of Allotment (Tentative) | Feb 11, 2026 | |
| Initiation of Refunds (Tentative) | Feb 12, 2026 | |
| Credit of Share (Tentative) | Feb 12, 2026 | |
| Listing date (Tentative) | Feb 13, 2026 | |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Arete 22 IPO P/E ratio is , as compared to Biopol Chemicals IPO P/E ratio of 19.73.
| Arete 22 IPO | Biopol Chemicals IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Arete 22 Ltd.'s revenue increased by 89% and profit after tax (PAT) rose by 473% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 99.40 | 89.88 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 65.81 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.73 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹116.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 86.12 | 38.10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 12.62 | 30.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.57 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹12.65 | ₹5.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 60.20 | 32.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Arete 22 IPO Retail Individual Investors (RII) are offered 0 shares while in Biopol Chemicals IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Arete 22 IPO and 6,86,400 shares in Biopol Chemicals IPO.
| Arete 22 IPO | Biopol Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 1,51,200 shares |
| QIB | 0 shares | 6,86,400 shares |
| NII | 0 shares | 10,94,400 shares |
| RII | 0 shares | 9,62,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 27,43,200 shares |
Arete 22 IPO subscribed in total, whereas Biopol Chemicals IPO subscribed 22.33x.
| Arete 22 IPO | Biopol Chemicals IPO | |
|---|---|---|
| QIB (times) | 21.05x | |
| NII (times) | 24.49x | |
| Big NII (times) | 27.49x | |
| Small NII (times) | 18.48x | |
| RII (times) | 20.80x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.33x |
